Viewing nowCombinationPimaropine Tablet 30/2.5 mg
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.

MFDS item code 202300084 · Approved 2023.01.06 · Insurance code 643105670
Treatment of essential hypertension not adequately controlled with fimasartan potassium monotherapy
This medication is used to lower blood pressure and help manage hypertension, particularly in cases where pimasartan monotherapy does not sufficiently control blood pressure necessitating additional treatment. Appropriate treatment methods are adjusted based on the patient's condition to effectively improve hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required for older adults aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in children and adolescents aged 18 years or younger.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, thus it must be discontinued immediately upon confirmation of pregnancy. It should not be administered to those with allergies to the active ingredients or related components, pregnant or breastfeeding individuals, patients undergoing renal dialysis, patients with moderate to severe liver impairment, patients with biliary obstruction, patients with specific kidney diseases and diabetes, individuals with lactose intolerance or certain genetic conditions, severe aortic stenosis patients, and patients in a shock state. Patients with low blood volume or sodium levels, individuals with impaired renal function, patients with renal vascular hypertension, patients with aortic and mitral valve stenosis, those with primary aldosteronism, patients with severe hypotension, elderly individuals, and those allergic to specific dyes included in this medication must take special care when using it. Various side effects such as dizziness, headaches, facial swelling, urinary disorders, insomnia, and flushing may occur, and if any unusual symptoms appear, the medical staff should be consulted. Blood pressure may drop too low during use, especially if blood volume or sodium is low, so symptoms of hypotension must be monitored, and appropriate measures should be taken if necessary. There is a risk of elevated potassium levels in blood during this medication use, so patients with heart failure or kidney diseases require regular blood tests. Drug interactions may occur if used with other antihypertensive drugs or specific medications, so if any other medications are being taken, it is crucial to inform the healthcare provider. This drug may have serious effects on the fetus during pregnancy, so it should not be used if planning a pregnancy or if pregnant, and it is not recommended during breastfeeding. For children under 18 years of age, the safety and efficacy of this medication have not been established, and it is advisable not to use it. For elderly individuals, no special dosage adjustment is necessary, but they should be cautious as they may respond more sensitively to the medication. It is safer not to administer this medication to patients with moderate to severe liver function impairment. Overdose may lead to serious symptoms such as hypotension, palpitations, and reflex tachycardia, requiring immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and must be stored in an opaque container. Also, it is safe to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication.
White, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aprogen BioLogic Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.